<p class="first" id="d5653701e155">Glycine modulates inflammatory processes mediated
by macrophages and adipocytes through
decreasing the secretion of TNF-α, IL-6, and leptin, while increasing adiponectin.
These effects have been associated with the inactivation of NF-κB in response to TNF-α,
across an increase of its inhibitor IκB-α in adipocytes. However, glycine upstream
mainly influences the IκB kinase (IKK) complex, a multi-protein kinase complex considered
a critical point in regulation of the NF-κB pathway; whether that is responsible for
the TNF-α-induced phosphorylation of IkB has not been explored. Additionally, although
previous studies have described glycine interactions with specific receptors (GlyR)
in different immune system cell types, it is currently unknown whether adipocytes
present GlyR. In this research, participation of the IKK-α/β complex in the inhibition
of the TNF-α/NF-κB pathway by glycine was evaluated and associated with the synthesis
and secretion of inflammatory cytokines in 3T3-L1 adipocytes. Furthermore, we also
explored GlyR expression, its localization on the plasmatic membrane, intracellular
calcium concentrations [Ca2+]i and strychnine antagonist action over the GlyR in these
cells. Glycine decreased the IKK-α/β complex and the phosphorylation of NF-κB, diminishing
the expression and secretion of IL-6 and TNF-α, but increasing that of adiponectin.
GlyR expression and its fluorescence in the plasma membrane were increased in the
presence of glycine. In addition, glycine decreased [Ca2+]i; whereas strychnine + glycine
treatment inhibited the activation of NF-κB observed with glycine. In conclusion,
the reduction of TNF-α and IL-6 and suppression of the TNF-α/NF-κB pathway by glycine
may be explained in part by inhibition of the IKK-α/β complex, with a possible participation
of GlyR in 3T3-L1 adipocytes.
</p>